Antibiotic discovery from environmental microorganisms of Brazil
Antibiotic discovery from environmental microorganisms of Brazil
批准号:
10316219
负责人:
Kim Lewis
金额:
$15.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-16 至 2023-11-30
关键词:
Acinetobacter baumanniiAnimalsAntibioticsAntimicrobial ResistanceBacteremiaBacteriaBindingBiodiversityBrazilCell WallCollectionDevelopmentDiffusionDrug resistanceEnvironmentEscherichia coliEukaryotaGoalsGram-Negative BacteriaGram-Positive BacteriaHigh Pressure Liquid ChromatographyInfectionKlebsiella pneumoniaeLabelLeadLocationMembrane ProteinsMethodsMiningMusMycobacterium tuberculosisNatural ProductsNatural Products ChemistryNatureNew EnglandPeptide HydrolasesPeptidoglycanPlanetsPlantsProbabilityProblem SolvingPseudomonas aeruginosaRainRecoveryResistanceResistance developmentResourcesRibosomal DNASamplingScientistSepticemiaSoilSourceStaphylococcus aureusStructureTeichoic AcidsThigh structureUniversitiesWorkWorld Health OrganizationWritingantimicrobialbasecombatcytotoxicitydrug discoveryexperienceforestmethicillin resistant Staphylococcus aureusmicrobialmicroorganismnovelnovel antibiotic classpathogenpreventresistance frequencyscreeningsoil sampling
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
We are currently experience a crisis of antimicrobial resistance, and the World Health Organization identified the
need to combat drug resistant Gram negative pathogens as “critical”. The last class of compounds acting against
Gram negative bacteria was introduced over 50 years ago.
The most effective strategy to prevent antimicrobial resistance is by introducing novel compounds that
act against AMR pathogens and have low probability of resistance development. We recently identified a novel
antimicrobial, teixobactin, that shows no detectable resistance against Gram positive bacteria (Ling et al., Nature
2015). Teixobactin is currently in IND-enabling development against important Gram positive AMR infections
such as MRSA bacteremia. We more recently discovered another natural product antibiotic, darobactin, with
unusually low resistance development that acts against Gram negative AMR pathogens.
While these are encouraging advances, a considerable effort is spent on rediscovery of the same
producing species and compounds. We reason that mining the rich diversity of Brazilian soils with our
approaches will provide access to novel antibiotic to combat the AMR crisis. The Brazilian rain forest has the
highest diversity of plants and animals, and we expect the same to be true for microorganisms. Indeed,
microorganism directly or loosely associate with eukaryotes, and degrade their products. The goal of this project
is to evaluate soils from Brazil for their microbial diversity, to screen isolates for compounds with Gram negative
activity, and to isolate and validate novel antimicrobials. If we are able to find novel antimicrobials from soils of
New England, it is reasonable to expect that the pace of discovery will increase once we access an environment
with the richest diversity on the planet.
This project brings together Dr. Kim Lewis, Northeastern University, an expert in drug resistance and
drug discovery, and Dr. Monica Pupo, University Sao Paulo, an expert in natural products chemistry. These
scientists collaborated on writing the proposal and will work closely together on its execution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering antimicrobials acting against MDR pathogens
-
批准号:10502744
-
项目类别:
-
资助金额:$113.65万
-
财政年份:2022
-
负责人:Kim Lewis
-
依托单位:
Discovering antimicrobials acting against MDR pathogens
-
批准号:10696159
-
项目类别:
-
资助金额:$114.15万
-
财政年份:2022
-
负责人:Kim Lewis
-
依托单位:
Evaluating darobactins as antimicrobial agents
-
批准号:10380760
-
项目类别:
-
资助金额:$59.52万
-
财政年份:2021
-
负责人:Kim Lewis
-
依托单位:
Evaluating darobactins as antimicrobial agents
-
批准号:10589109
-
项目类别:
-
资助金额:$59.52万
-
财政年份:2021
-
负责人:Kim Lewis
-
依托单位:
Evaluating darobactins as antimicrobial agents
-
批准号:10177579
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2021
-
负责人:Kim Lewis
-
依托单位:
Antibiotic discovery from environmental microorganisms of Brazil
-
批准号:9890152
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2019
-
负责人:Kim Lewis
-
依托单位:
Antibiotic discovery from environmental microorganisms of Brazil
-
批准号:10523537
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2019
-
负责人:Kim Lewis
-
依托单位:
A general mechanism of persister formation
-
批准号:10291419
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2018
-
负责人:Kim Lewis
-
依托单位:
A general mechanism of persister formation
-
批准号:10053305
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2018
-
负责人:Kim Lewis
-
依托单位:
Resolving the bottleneck in antibiotic discovery
-
批准号:9150912
-
项目类别:
-
资助金额:$185.73万
-
财政年份:2016
-
负责人:Kim Lewis
-
依托单位:
Admin Core
-
批准号:9150913
-
项目类别:
-
资助金额:$5.98万
-
财政年份:2016
-
负责人:Kim Lewis
-
依托单位:
Culturing Uncultivatable Gut Microorganisms
-
批准号:8118214
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
A High-Throughput Screen for Specific Anti-M. tuberculosis Compounds
-
批准号:8260859
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
A High-Throughput Screen for Specific Anti-M. tuberculosis Compounds
-
批准号:8065515
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
A High-Throughput Screen for Specific Anti-M. tuberculosis Compounds
-
批准号:7986588
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
Culturing Uncultivatable Gut Microorganisms
-
批准号:8292159
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
Culturing Uncultivatable Gut Microorganisms
-
批准号:7933279
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
Culturing Uncultivatable Gut Microorganisms
-
批准号:8330380
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2010
-
负责人:Kim Lewis
-
依托单位:
Super-persistent cells and the paradox of untreatable infections
-
批准号:7764848
-
项目类别:
-
资助金额:$100.85万
-
财政年份:2009
-
负责人:Kim Lewis
-
依托单位:
Super-persistent cells and the paradox of untreatable infections
-
批准号:7936076
-
项目类别:
-
资助金额:$105.09万
-
财政年份:2009
-
负责人:Kim Lewis
-
依托单位:
海外基金